MENU
JUN 17, 2020 Opens: 6:00 AM PT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

Coronavirus Virtual Webinar Series



 

A novel coronavirus emerged in China in late 2019; it has been officially named by the World Health Organization (WHO) as CoVID-19. LabRoots will be working to educate the community about this pathogen in an ongoing series of webinars.

The First Event of our Coronavirus Virtual Webinar Series was a great success! It is now available for on-demand viewing. Our next set of webinars will go live on June 17th.

This virus is a member of the coronavirus family and is zoonotic, or transmissible from animals to humans, and is thought to have originated in bats like other coronaviruses. Researchers are working to learn more about how this virus made the jump from animals to humans, probably through an intermediate species.

The CoVID-19 virus has already infected tens of thousands of people worldwide. In China, hundreds have been killed, leading the World Health Organization to declare an international health emergency, one of only four that have ever been declared.

Researchers have found evidence that the virus can be transmitted by people that don't have symptoms. Scientists are working to find ways to treat the fever, respiratory illness, cough, and breathing difficulties it causes.

You can learn more from this event about:

  • The Origins and Symptoms of CoVID-19
  • Laboratory tests in CoVID-19 Diagnosis
  • Prevention, Containment and Treatment of CoVID-19 Cases

This free event does not require any travel, and will remain ongoing; webinars will continue to occur in the future as we find out more about this pathogen. The content will be available for unlimited, on-demand viewing. The global community will be able to interact using chat sessions and live-streaming. This seamless connectivity will be available on any desktop or mobile device so you can view, learn and interact.

Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Plan now to have your poster included in the Coronavirus webinar series and virtual event. Submission is free. Submit your abstract here.

Continuing Education
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar series, you can earn 1 Continuing Education credit per presentation.

 

Use #LRcoronavirus to follow the conversation!


Speakers
  • Director, Market Strategy for Microbial and Cancer Genomics, Pacific Biosciences
  • Head of Virology Unit of KingMed Diagnostics
  • Director, Division of Infectious Diseases, Craig-Weaver Professor of Pediatrics, Professor of Pathology, Microbiology & Immunology, Professor at Vanderbilt University
  • Clinical Scientist, Author, Consultant
  • Director, Microfluidics Product Management, Fluidigm
  • Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital Sichuan Provincial Center for Clinical Laboratories (SPCCL)
  • Deputy Director of Central Lab of DIAN Diagnostics
  • Senior Scientist of Antibody Research Group at GenScript ProBio
  • Market Development, Thermo Fisher Scientific
  • Biosearch Technologies Market Segment Manager MDx, LGC
  • NACCCA Board Secretary, Clinical Fellow of UC San Francisco
  • Senior Product Manager, Complete Genomics Facility, MGI
  • Sr. Scientific Affairs Manager, Roche Diagnostic Corporation
  • Chief Science Officer, Fluidigm
  • Product Manager, Antibody Therapeutics, Berkeley Lights, Inc.
  • Manager of the Field Applications Group at GenScript USA, Inc
  • China Chief Medical Officer of Cepheid at the Danaher Diagnostic Platform in Shanghai
  • Chairman of Chinese Society of Laboratory Medicine, Director of Clinical Laboratory of PLA General Hospital, Chief Physician
  • Professor & Director, Emerging Infectious Diseases Program, Duke-NUS Medical School, Singapore
  • Associate Professor, Pathology, Vice Director of Clinical Laboratory Medicine Center, Shanghai General Hospital, affiliated to Shanghai Jiaotong University
  • Pathologist (ABP-AP/CP, Hem), Vice President of ADICON Medical Laboratories
  • Laboratory Director at BGI

Show Resources
You May Also Like
APR 29, 2020 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
APR 29, 2020 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Luminex's xMAP® Technology enables the evaluation of up to 500 analytes simultaneously in a single well, known as multiplexing. xMAP Technology uses color-coded microspheres as the substrate...
NOV 12, 2020 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
NOV 12, 2020 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Ten years ago LabRoots launched a new system of learning for a global scientific audience. Now, the 2020 Clinical Diagnostics and Research Virtual Event will again bring together clinicians,...
SEP 08, 2020 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
SEP 08, 2020 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to bring academia and industry, research experts, virologists, microbiologists, healthcare professionals, and leading biomedical scientists under one roof at our 1st Annua...
SEP 23, 2020 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
SEP 23, 2020 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots and the Cell Biology Planning Committee are please to announce the 4th Annual Cell Biology Virtual Event, providing an opportunity to discuss recent discoveries in biological researc...
MAY 06, 2020 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
MAY 06, 2020 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is please to announce our 2nd Forensic Sciences Virtual onMay 6, 2020. The exciting field of forensic sciences is focused on a blend of biology, ch...
MAR 24, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
MAR 24, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is pleased to announce the 4th Annual 2021 Cannabis Sciences Virtual Event . LabRoots will host the event on March 24, 2021. The Cannabis Sciences planning committee will be plannin...
Infographic

All you need to know about 2019 Novel Coronavirus (CoVID-19)

CoVID-19 is spreading with wildfire speed, to date, there are 215,565 of confirmed CoVID-19 cases and 8893 covid-19 related deaths in the world and these numbers are being updated constantly (view current outbreak status). Many countries, including the U.S, are now in a state of a public health emergency. There is no known medication or vaccine to this virus, and currently, the only measure of defense is social isolation and hand hygiene. Here is what we know so far about the CoVID-19 virus. Keep safe and make sure you follow the CDC guidelines.

Below are some fast facts about CoVID-19. To view the comprehensive and to-the-point infographic, click here

View the comprehensive infographic

View the comprehensive infographic

View the comprehensive infographic

View the comprehensive infographic

View the comprehensive infographic

View the comprehensive infographic

Agenda
  • APR 02, 2020 2:30 PM PDT
    COVID-19 Total Solutions for Detection and Surveillance
    Sponsored By: BGI Americas,
    MGI Americas
    SEE ABSTRACT | Sponsored by: MGI Americas | Continuing Education: Florida CE | P.A.C.E. CE
    Subodh Nimkar
    Senior Product Manager, Complete Genomics Facility, MGI
    Pan Zhang, PhD
    Laboratory Director at BGI
  • APR 02, 2020 2:30 PM PDT
    Opportunities for using PacBio Long-read Sequencing for COVID-19 Research
    Meredith Ashby, PhD
    Director, Market Strategy for Microbial and Cancer Genomics, Pacific Biosciences
    Sponsored By: PacBio
  • APR 02, 2020 1:00 PM PDT
    PANEL: Specimen Collection and Laboratory Safety
    Jason Chen, MD
    Head of Virology Unit of KingMed Diagnostics
    Yushen Jiang, MD
    Deputy Director of Central Lab of DIAN Diagnostics
    Ruben Luo, PhD
    NACCCA Board Secretary, Clinical Fellow of UC San Franc...
    Chengbin Wang, MD
    Chairman of Chinese Society of Laboratory Medicine, Dir...
    Frank Yang, MD, PhD
    Pathologist (ABP-AP/CP, Hem), Vice President of ADICON...
  • APR 02, 2020 1:00 PM PDT
    Rapid Response to the Coronavirus Outbreak: How Collaboration Meets the Challenge
    Geert Koene, PhD
    Biosearch Technologies Market Segment Manager MDx, LGC
    Sponsored By: Biosearch Technologies
  • APR 02, 2020 11:30 AM PDT
    COVID-19 infection mechanism, tools for testing and therapeutic antibody development
    Sponsored By: GenScript
    Manzhu Kang, PhD
    Senior Scientist of Antibody Research Group at GenScrip...
    Sean Taylor
    Manager of the Field Applications Group at GenScript US...
  • APR 02, 2020 11:30 AM PDT
    Implementation of Molecular Diagnostics for SARS-CoV-2
    Li Jiang, MD, PhD
    Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital Sichuan Provincial Center for Clinical Laboratories (SPCCL)
  • APR 02, 2020 10:00 AM PDT
    Laboratory Tests for CoVID-19
    Jun Wu, PhD
    Associate Professor, Pathology, Vice Director of Clinical Laboratory Medicine Center, Shanghai General Hospital, affiliated to Shanghai Jiaotong University
  • APR 02, 2020 10:00 AM PDT
    SARS-CoV-2 (CoVID-19: Emergence, Biology, and Countermeasures)
    Mark Denison, MD
    Director, Division of Infectious Diseases, Craig-Weaver Professor of Pediatrics, Professor of Pathology, Microbiology & Immunology, Professor at Vanderbilt University
    Continuing Education: Florida CE | P.A.C.E. CE
  • APR 02, 2020 8:30 AM PDT
    Laboratory Diagnosis of SARS-CoV-2 Infections: Current Status
    Yi-Wei Tang, MD, PhD, F(AAM), FIDSA
    China Chief Medical Officer of Cepheid at the Danaher Diagnostic Platform in Shanghai
  • APR 02, 2020 8:30 AM PDT
    Rapid Discovery of Therapeutic Antibodies for SARS-CoV-2 and Other Viral Pandemics
    Anupam Singhal
    Product Manager, Antibody Therapeutics, Berkeley Lights, Inc.
    Sponsored By: Berkeley Lights
  • APR 02, 2020 7:30 AM PDT
    COVID-19: Putting together the pieces of the pandemic
    Rowshanak Hashemiyoon, PhD
    Clinical Scientist, Author, Consultant
  • APR 02, 2020 7:30 AM PDT
    From Hendra to Wuhan: emerging bat-borne viruses in a quarter of century
    Linfa Wang, PhD
    Professor & Director, Emerging Infectious Diseases Program, Duke-NUS Medical School, Singapore
  • APR 02, 2020 6:00 AM PDT
    A Multi-Omic Approach to Detection and Characterization of Viral Pathogens and Their Impact on the Immune System
    Sponsored By: Fluidigm
    Bill Hunt, MS
    Director, Microfluidics Product Management, Fluidigm
    Andrew Quong, PhD
    Chief Science Officer, Fluidigm
  • APR 02, 2020 6:00 AM PDT
    Enhanced. Rapid Target Identification by NGS for Vaccine Development
    Cris Kinross
    Market Development, Thermo Fisher Scientific
    Sponsored By: Thermo Fisher Scientific
  • Laboratory tests in CoVID-19 diagnosis and treatment
  • APR 02, 2020 8:30 AM PDT
    Laboratory Diagnosis of SARS-CoV-2 Infections: Current Status
    Yi-Wei Tang, MD, PhD, F(AAM), FIDSA
    China Chief Medical Officer of Cepheid at the Danaher Diagnostic Platform in Shanghai
  • APR 02, 2020 10:00 AM PDT
    Laboratory Tests for CoVID-19
    Jun Wu, PhD
    Associate Professor, Pathology, Vice Director of Clinical Laboratory Medicine Center, Shanghai General Hospital, affiliated to Shanghai Jiaotong University
  • APR 02, 2020 11:30 AM PDT
    Implementation of Molecular Diagnostics for SARS-CoV-2
    Li Jiang, MD, PhD
    Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital Sichuan Provincial Center for Clinical Laboratories (SPCCL)
  • APR 02, 2020 1:00 PM PDT
    PANEL: Specimen Collection and Laboratory Safety
    Jason Chen, MD
    Head of Virology Unit of KingMed Diagnostics
    Yushen Jiang, MD
    Deputy Director of Central Lab of DIAN Diagnostics
    Ruben Luo, PhD
    NACCCA Board Secretary, Clinical Fellow of UC San Franc...
    Chengbin Wang, MD
    Chairman of Chinese Society of Laboratory Medicine, Dir...
    Frank Yang, MD, PhD
    Pathologist (ABP-AP/CP, Hem), Vice President of ADICON...
  • APR 02, 2020 6:00 AM PDT
    Enhanced. Rapid Target Identification by NGS for Vaccine Development
    Cris Kinross
    Market Development, Thermo Fisher Scientific
    Sponsored By: Thermo Fisher Scientific
  • APR 02, 2020 11:30 AM PDT
    COVID-19 infection mechanism, tools for testing and therapeutic antibody development
    Sponsored By: GenScript
    Manzhu Kang, PhD
    Senior Scientist of Antibody Research Group at GenScrip...
    Sean Taylor
    Manager of the Field Applications Group at GenScript US...
  • APR 02, 2020 2:30 PM PDT
    Opportunities for using PacBio Long-read Sequencing for COVID-19 Research
    Meredith Ashby, PhD
    Director, Market Strategy for Microbial and Cancer Genomics, Pacific Biosciences
    Sponsored By: PacBio
  • APR 02, 2020 2:30 PM PDT
    COVID-19 Total Solutions for Detection and Surveillance
    Sponsored By: BGI Americas,
    MGI Americas
    SEE ABSTRACT | Sponsored by: MGI Americas | Continuing Education: Florida CE | P.A.C.E. CE
    Subodh Nimkar
    Senior Product Manager, Complete Genomics Facility, MGI
    Pan Zhang, PhD
    Laboratory Director at BGI
  • Prevention, Containment and Treatment of CoVID-19 Cases
  • APR 02, 2020 10:00 AM PDT
    SARS-CoV-2 (CoVID-19: Emergence, Biology, and Countermeasures)
    Mark Denison, MD
    Director, Division of Infectious Diseases, Craig-Weaver Professor of Pediatrics, Professor of Pathology, Microbiology & Immunology, Professor at Vanderbilt University
    Continuing Education: Florida CE | P.A.C.E. CE
  • APR 02, 2020 8:30 AM PDT
    Rapid Discovery of Therapeutic Antibodies for SARS-CoV-2 and Other Viral Pandemics
    Anupam Singhal
    Product Manager, Antibody Therapeutics, Berkeley Lights, Inc.
    Sponsored By: Berkeley Lights
  • APR 02, 2020 1:00 PM PDT
    Rapid Response to the Coronavirus Outbreak: How Collaboration Meets the Challenge
    Geert Koene, PhD
    Biosearch Technologies Market Segment Manager MDx, LGC
    Sponsored By: Biosearch Technologies
  • APR 02, 2020 6:00 AM PDT
    A Multi-Omic Approach to Detection and Characterization of Viral Pathogens and Their Impact on the Immune System
    Sponsored By: Fluidigm
    Bill Hunt, MS
    Director, Microfluidics Product Management, Fluidigm
    Andrew Quong, PhD
    Chief Science Officer, Fluidigm
  • The Origins and Symptoms of CoVID-19
  • APR 02, 2020 7:30 AM PDT
    From Hendra to Wuhan: emerging bat-borne viruses in a quarter of century
    Linfa Wang, PhD
    Professor & Director, Emerging Infectious Diseases Program, Duke-NUS Medical School, Singapore
  • APR 02, 2020 7:30 AM PDT
    COVID-19: Putting together the pieces of the pandemic
    Rowshanak Hashemiyoon, PhD
    Clinical Scientist, Author, Consultant
Speakers

  • Meredith Ashby, PhD
    Director, Market Strategy for Microbial and Cancer Genomics, Pacific Biosciences
    Biography
      Meredith Ashby is the Director of Market Strategy for Microbial Genomics, Cancer and Immunology at Pacific Biosciences. She completed her Ph.D. at Caltech mapping the gene regulatory networks that direct sea urchin development just as the sea urchin genome was being sequenced. Inspired by the impact of genome sequencing on her research, she joined PacBio after a postdoc at UCSF. She has been with the company since 2009 and has worked in R&D on both sequencing optimization and bioinformatics application development. She is now focused on facilitating the use of PacBio long read sequencing to solve the unmet needs of scientists seeking to understand the incredibly diverse range of microbes that live in, on and around us and the systems we depend on.
    • Jason Chen, MD
      Head of Virology Unit of KingMed Diagnostics
    • Mark Denison, MD
      Director, Division of Infectious Diseases, Craig-Weaver Professor of Pediatrics, Professor of Pathology, Microbiology & Immunology, Professor at Vanderbilt University
      Biography
        Mark Denison M.D. is the Craig-Weaver Professor of Pediatrics, Pathology, Microbiology & Immunology at Vanderbilt University Medical Center in Nashville, TN. Dr. Denison has performed over 25 years of NIH-funded research focused on the replication, pathogenesis, and evolution of coronaviruses, a family of RNA viruses from which SARS-CoV emerged. Coronaviruses cause respiratory infections in humans and increasingly are thought to be ubiquitous among mammalian species. Notably, a large number of novel coronaviruses have been identified in bats, suggesting that bats may be critical for the emergence of coronaviruses in other species. Coronaviruses may have unique potential for cross-species movement. They encode novel RNA synthesis and probable RNA proofreading functions, thereby conferring the ability to maintain large and complex genomes and to respond to host or other environmental changes. The Denison lab focuses on determining the mechanisms of coronavirus evolution and host species movement and adaptation, using synthetic biology and reverse genetics. Dr. Denison has served on the steering committee for the Southeast Regional Center of Excellence in Emerging Infections and Biodefense for the past eight years. In addition, he is the Chair of the Vanderbilt Institutional Biosafety Committee and has served on multiple Government and international panels involved in review or consideration of biodefense, biosecurity, and synthetic biology.
      • Rowshanak Hashemiyoon, PhD
        Clinical Scientist, Author, Consultant
        Biography
          Dr. Rowshanak Hashemiyoon is a clinical scientist, author, and consultant. Her work focuses on identifying the altered network dynamics underlying the dysfunctional brain states of neuropsychiatric and neurologic disorders, and fostering the development of novel treatments which alleviate the symptoms of these disorders. Dr. Hashemiyoon was the founder and head of the Human Brain and Behavior Laboratory in the Department of Stereotactic and Functional Neurosurgery at the University Hospital of Cologne in Germany, where she converged methods of computational neuroscience with clinical care in order to optimize neurosurgical patient outcomes. Dr. Hashemiyoon did her post-doctoral fellowship at the Yale University School of Medicine before taking a faculty position at the Center for Complex Systems at FAU in Florida. While at the University of Miami, she reported the first longitudinal study of the effects of deep brain stimulation on the underlying neuropathophysiology in a psychiatric disorder in humans. Her work described the dynamics of neuronal activation in correlation with the symptomatology observed in Tourette syndrome, offering important insights into tic genesis and expression.
        • Bill Hunt, MS
          Director, Microfluidics Product Management, Fluidigm
          Biography
            Bill Hunt is a Director of Microfluidics Product Management and has been with Fluidigm for four years. Prior to joining Fluidigm, he was a Marketing Director at Celera Corporation where he managed the commercial relationship with Abbott Molecular, Celera's global distribution partner. Bill earned both Bachelor and Master degrees in Genetics and Molecular Biology from the Pennsylvania State University.
          • Li Jiang, MD, PhD
            Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital Sichuan Provincial Center for Clinical Laboratories (SPCCL)
          • Yushen Jiang, MD
            Deputy Director of Central Lab of DIAN Diagnostics
          • Manzhu Kang, PhD
            Senior Scientist of Antibody Research Group at GenScript ProBio
            Biography
              Dr. Manzhu Kang received her Ph. D. from the University of California Los Angeles, with a dissertation focusing on the impact of combinatorial therapy on the evolution of drug resistance. Dr. Kang is a senior scientist of antibody research group at GenScript ProBio. She is in charge of the single B cell screening platform for antibody drug discovery
            • Cris Kinross
              Market Development, Thermo Fisher Scientific
              Biography
                Cris Kinross graduated in Neuroscience from Allegheny College, where she investigated the molecular role of stress and aging on brain resilience. Her focus on NGS development have contributed to the democratization and simplification of NGS technology.
              • Geert Koene, PhD
                Biosearch Technologies Market Segment Manager MDx, LGC
                Biography
                  Geert holds a PhD in immuno-oncology from Utrecht University, the Netherlands and has been active in MDx industry for over 15 years in various global roles. Joining LGC, Biosearch technologies 1.5 years ago, he oversees the strategic development for the MDx segment.
                • Ruben Luo, PhD
                  NACCCA Board Secretary, Clinical Fellow of UC San Francisco
                • Subodh Nimkar
                  Senior Product Manager, Complete Genomics Facility, MGI
                  Biography
                    Subodh Nimkar is a Senior Product Manager in MGI based in Complete Genomics facility in San Jose CA. His primary responsibilities include management and commercialization of the novel CoolMPS Chemistry for Massively Parallel Sequencing on DNBSEQ platforms. He is also responsible for product management and commercialization of MGIs sequencing solutions in AMERICAS. Over last 20 years he has worked with ABI, Thermo Fisher, Agilent and Streck. He has authored two key patents at ABI and commercialized solutions based on that. He holds a Masters in Chemical Engineering and MBA.
                  • Jamie Phillips, PhD
                    Sr. Scientific Affairs Manager, Roche Diagnostic Corporation
                    Biography
                      Jamie obtained her Masters and PhD from the University of Georgia, in Infectious Diseases. During her graduate studies she focused on Coronavirus viral genome annotation and identification of genes associated with pathogenicity. In between her Masters and PhD program she spent time in Ghana aiding the Ministry of Health with developing a vaccine program for women and children. Following her graduate studies, she held a two-year postdoctoral position serving as the primary molecular virologist in a small diagnostic lab, while concurrently serving as an Associate professor of biology at Georgia Gwinnett College (GGC). At GGC she taught a microbiology lab and lecturer. In the diagnostic lab she utilized primary virus isolation, serum neutralization assays, and real time PCR to investigate the origin of outbreaks and the evolution of the pathogens. After her postdoctoral position, she held a brief research associate position at the University of California Davis (UC Davis) where she aided in validating diagnostic assays and looking at the role co-infections play with influenza viruses. She left UC Davis for a small biotech company located in southern California looking to relocate to Eatonton, Ga. In 2014, Jamie joined Aalto Scientific, where she served as the Director of Research. Aalto Scientific is a privately owned manufacturer of control and calibration material for clinical chemistry analyzers. During her time there she oversaw the Research and Development department's relocation serving as the primary source of knowledge transfer for all open design control projects. Jamie joined Roche Diagnostics in their Medical and Scientific Affairs Division in Fishers, Indiana supporting their molecular Point of Care (POC) devices. In this current role she oversees the Medical Plan and investigator initiated studies associated with the cobas Liat, a CLIA waived molecular POC device. Additionally, she currently serves as a subject matter expert for respiratory pathogens and antimicrobial stewardship initiatives.
                    • Andrew Quong, PhD
                      Chief Science Officer, Fluidigm
                      Biography
                        Andrew Quong joined Fluidigm's executive team as Chief Science Officer in June 2019. Prior to this, Andrew was the Director of Strategic Scientific Initiatives and Partnerships at the Frederick National Laboratory for Cancer Research, a federally funded research and development center sponsored by the National Cancer Institute. Frederick National Laboratory is at the forefront of basic, translational and clinical science with a focus on cancer, AIDS and infectious disease. Prior to joining the Frederick National Laboratory, Quong served as a faculty member in the Department of Cancer Biology at Thomas Jefferson University and the Department of Oncology at Georgetown University.
                      • Anupam Singhal
                        Product Manager, Antibody Therapeutics, Berkeley Lights, Inc.
                        Biography
                          Anupam Singhal earned his PhD from the University of British Columbia and has over 15 years of experience in nanotechnology and microfluidics at UBC, the University of Toronto and Stanford University. His work has been cited over 600 times and resulted in several patents for molecular disease diagnosis, antibody discovery, and development of production cell-lines for biologics. At Berkeley Lights, Anupam leads the development of next-generation platforms for the discovery and development of antibody therapeutics.
                        • Sean Taylor
                          Manager of the Field Applications Group at GenScript USA, Inc
                          Biography
                            Sean Taylor holds a Ph.D. and an MBA from McGill University and has spent the past ten years publishing articles, providing seminars, workshops and training videos to help the global scientific community achieve excellent data from western blotting, qPCR and digital PCR experiments. He has managed teams of Field Application Scientists (FAS) in Canada for over a decade who have helped thousands of scientists achieve their research goals. In his current role as North American FAS Manager for GenScript, he leads a dedicated team to continue the tradition of providing pertinent and timely information to help the scientific community overcome research hurdles to accelerate the production of high quality, publishable data, cost-effectively.
                          • Yi-Wei Tang, MD, PhD, F(AAM), FIDSA
                            China Chief Medical Officer of Cepheid at the Danaher Diagnostic Platform in Shanghai
                            Biography
                              Dr. Yi-Wei Tang is currently the China Chief Medical Officer of Cepheid at the Danaher Diagnostic Platform in Shanghai. He obtained his medical training from Fudan University Shanghai School of Medicine and Ph.D. in microbiology and immunology from Vanderbilt University. He was a Lecturer and Clinical Fellow at the Mayo Clinic, a Professor at the Vanderbilt University School of Medicine, Chief of the Clinical Microbiology Service at the Memorial Sloan-Kettering Cancer Center and a Professor of Pathology and Laboratory Medicine at the Weill Medical College of Cornell University in New York City, USA. He has been engaged in developing and evaluating new and advanced microbiological diagnostic testing procedures. Dr. Tang ranks among the top of the scientific field in clinical and molecular microbiology, as evidenced by his election as an Editor for the Journal of Clinical Microbiology, an Associate Editor for the Journal of Molecular Diagnostics, an Associate Editor for the Emerging Microbes and Infection, and a Fellow of the American Academy for Microbiology and of the Infectious Disease Society of America. Dr. Tang has been recognized for his extraordinary expertise in the molecular microbiology diagnosis and monitoring with over 200 peer-reviewed articles and over 100 book chapters in this field during the past 20 years.
                            • Chengbin Wang, MD
                              Chairman of Chinese Society of Laboratory Medicine, Director of Clinical Laboratory of PLA General Hospital, Chief Physician
                            • Linfa Wang, PhD
                              Professor & Director, Emerging Infectious Diseases Program, Duke-NUS Medical School, Singapore
                              Biography
                                Linfa Wang, PhD, is the director of the Programme in Emerging Infectious Diseases at Duke-NUS Medical School, Singapore. Having completed his Bachelor's degree in 1982 at the East China Normal University in Shanghai, Wang went on to obtain his PhD at the University of California, Davis. His early research was at the Monash Centre for Molecular Biology and Medicine. In 1990, he joined the Commonwealth Scientific and Industrial Research Organization (CSIRO), Australian Animal Health Laboratory (AAHL), where he played a leading role in identifying bats as the natural host of the Severe Acute Respiratory Syndrome (SARS) virus. His research then extended from bat-borne viruses to bettering understanding virus-bat interaction, and he led an international team carrying out comparative genomic analysis of two bat species. They discovered an important link between adaptation to flight and bats' ability to counter DNA damage repair as a result of fast metabolism and to co-exist with a large number of viruses without developing clinical diseases. Wang's work has been recognized internationally through various international awards, numerous invited speeches at major international conferences and many top scientific publications, including Science, Nature, Nature Reviews in Microbiology, Lancet Infectious Diseases and the Proceedings of the National Academy of Sciences (PNAS), along with five patents and many invited book chapters. He holds a number of honorary positions and memberships and has received numerous awards such as the 2014 Eureka Prize for Research in Infectious Diseases. In 2010, Wang was elected as a fellow of Australian Academy of Technological Sciences and Engineering in recognition of his expertise in new and emerging diseases. Wang is also active internationally by serving on various editorial boards for publication in the areas of virology, microbiology and infectious diseases. He is currently the editor-in-chief of the Virology Journal.
                              • Jun Wu, PhD
                                Associate Professor, Pathology, Vice Director of Clinical Laboratory Medicine Center, Shanghai General Hospital, affiliated to Shanghai Jiaotong University
                                Biography
                                  Dr. Wu is an Associate professor in Pathology, as well Vice Director of Clinical Laboratory Medicine Center at the Shanghai General Hospital which is affiliated to Shanghai Jiaotong University. He is also a Youth member of Chinese Society of Laboratory Medicine, as well as a Member of Shanghai Medical Association, Molecular Diagnostics Branch, and a Member of Chinese Expert Committee of Experimental Medicine, Pathology Branch.
                                • Frank Yang, MD, PhD
                                  Pathologist (ABP-AP/CP, Hem), Vice President of ADICON Medical Laboratories
                                • Pan Zhang, PhD
                                  Laboratory Director at BGI
                                  Biography
                                    Pan Zhang serves as the Laboratory Director at BGI, which provides high-throughput NGS services to a wide range of customers. Prior of joining BGI, she was the Director of the Sequencing and Microarray Center at Coriell Institute for Medical Research, where she oversaw genome analyses of thousands of participants in precision medicine research studies. Before Coriell, Pan was a senior clinical research scientist at Weill Cornell Medicine New York-Presbyterian Hospital, where she was responsible for developing next-generation sequencing for clinical oncology tests in a molecular diagnostic laboratory and translational research studies. She earned her advanced degree in neuropharmacology at Beijing University Health Science Center and her medical degree at Shanxi Medical University. She acquired her doctorate in biomedical sciences from Rutgers Biomedical and Health Sciences.
                                  Posters

                                  Posters

                                   

                                  POSTER SUBMISSION GUIDELINES

                                  Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PowerPoint file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer-reviewed. Submission is free.

                                   

                                  SUBMIT YOUR ABSTRACT

                                  Enter the following information to this Submission Form:

                                  • Poster Title
                                  • Your Name
                                  • Your Institution
                                  • Your Email
                                  • Abstract describing the poster

                                   

                                  All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event.

                                  If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster. LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.

                                  Questions? Email Posters@LabRoots.com

                                  LabRoots Policy

                                  Sponsored by

                                  For information on becoming a sponsor or exhibitor, please click here.


                                  C.E. Credits

                                  The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


                                  Help

                                  General LabRoots Questions

                                  email support@labroots.com  

                                  Virtual Events and Webinars

                                  Supported Configurations

                                  • Operating System Internet Explorer Firefox Chrome Safari
                                    Vista IE8+ FF10+ Chrome15+
                                    Windows 7 IE8+ FF10+ Chrome15+
                                    Windows 8 IE10 FF10+ Chrome15+
                                    Mac OS X   FF10+ Chrome15+ Safari5.1+
                                  • Cookie settings: session cookies enabled
                                  • Browser configuration must have JavaScript enabled
                                  • Adobe Flash player 10.2 or later

                                  To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                                  Internet Connection

                                  • A minimum of 100Kbps is recommended for audio-only events
                                  • A minimum of 300Kbps is recommended for speaker on-video events

                                  Computer Equipment

                                  • Screen Resolution: Minimum 1024x768
                                  • Video Card: 65,000 colors minimum
                                  • Sound card and speakers (or headphones) for hearing webcast in full format
                                  • Audio Card: 16-bit minimum
                                  • RAM: 512MB of free RAM

                                  Firewall Protocol

                                  • HTTP on port 80 or HTTPS on port 443
                                  • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                                  • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                                  Work-At-Home Attendees

                                  • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                                  For A Seamless Experience

                                  When using a mobile device, FREE Mobile Apps are available:

                                  - For viewing Webinars:

                                  - For viewing Virtual Events

                                  Attendee Guide

                                  • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                                  Virtual Event and Webinar Support:

                                  Continuing Education (CME/CE) Support

                                  Loading Comments...
                                  Show Resources